| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $253.0M | — | +19.7% |
| R&D Expense | $19.5M | — | +2.4% |
| SG&A Expense | $63.6M | — | +16.3% |
| Operating Income | $62.0M | — | +65.8% |
| Pre-tax Income | $70.7M | — | +60.8% |
| Income Tax | $14.4M | — | +164.9% |
| Net Income | $38.8M | — | +52.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $170.7M | +99.1% | +94.9% |
| Accounts Receivable | $1.1M | -44.8% | +107.4% |
| Current Assets | $864.9M | +13.1% | +48.6% |
| Total Assets | $1.42B | +9.1% | +28.0% |
| Current Liabilities | $860.0M | +13.2% | +24.9% |
| Total Liabilities | $1.21B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $190.4M | — | +93.6% |
| Capital Expenditures | $4.9M | — | -31.2% |
| Investing Cash Flow | -$21.4M | — | -122.9% |
| Financing Cash Flow | -$83.9M | — | +51.0% |
| Free Cash Flow | $185.5M | — | +103.2% |
| +22.7% |
| Stockholders' Equity | $185.3M | +4.3% | +58.8% |